TNF Pharmaceuticals Inc. (TNFA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

TNF Pharmaceuticals Inc.

NASDAQ: TNFA · Real-Time Price · USD
3.48
-0.32 (-8.42%)
At close: Sep 03, 2025, 3:59 PM
3.50
0.57%
After-hours: Sep 03, 2025, 05:59 PM EDT

TNF Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-10.17M -17.12M -15.28M -28.2M
Interest Income
351.81K 455.57K 83.99K 8.91K
Pretax Income
-23.36M -4M -15.2M -29.89M
Net Income
-23.36M -4M -15.2M -29.89M
Selling & General & Admin
5.22M 8.49M 6.22M 21.46M
Research & Development
3.44M 7.87M 9.07M 6.75M
Other Expenses
1.51M 762.83K n/a n/a
Operating Expenses
10.17M 17.12M 15.28M 28.2M
Interest Expense
n/a n/a n/a 608.46K
Selling & Marketing Expenses
439.63K 3.05M n/a 15.04M
Cost & Expenses
10.17M 17.12M 15.28M 28.2M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
24.37K 15.43K 12.94K 11.67K
Shares Outstanding (Diluted)
24.37K 15.43K 12.94K 11.67K
EPS (Basic)
-1.11K -533 -1.17K -2.56K
EPS (Diluted)
-1.11K -533 -1.17K -2.56K
EBITDA
-23.36M -4M -15.2M -29.28M
EBIT
-23.36M -4M -15.2M -29.28M
Depreciation & Amortization
2.78M 13.12M 15.28M 18.33K